Author

John C. Mansour

Observed names: J. Mansour, J.C. Mansour, John C Mansour, John Mansour, John C. Mansour, Mansour, John C.

Institution: The University of Texas Southwestern Medical Center

Observed institutions: Parkland Health & Hospital System, Memorial Sloan Kettering Cancer Center, University of Wisconsin–Madison, University of Arizona, Jichi Medical University, VA North Texas Health Care System, Dallas VA Medical Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center

ORCID: 0000-0001-6346-9429

Observed ORCID: 0000-0001-6346-9429

OpenAlex ID: A5053019255

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

2015 · Agnieszka K. Witkiewicz, Elizabeth A. McMillan, et al. · Nature Communications · 1,114

PDF

Hilar Cholangiocarcinoma: expert consensus statement

2015 · John C. Mansour, Thomas A. Aloia, et al. · HPB · 415

PDF

Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis

2016 · Ali A. Mokdad, Rebecca M. Minter, et al. · Journal of Clinical Oncology · 402

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

2023 · Mary B. Daly, Tuya Pal, et al. · Journal of the National Comprehensive Cancer Network · 320

PDF

Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome

2013 · Adam C. Yopp, John C. Mansour, et al. · Annals of Surgical Oncology · 244

An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration

2014 · Raghu R. Chivukula, Guanglu Shi, et al. · Cell · 211

PDF

Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts

2022 · Alessandro Paniccia, Patricio M. Polanco, et al. · Gastroenterology · 205

Pancreatic endocrine tumors

2004 · John C Mansour, Herbert Chen · Journal of Surgical Research · 153

Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma

2015 · Yuhree Kim, Georgios A. Margonis, et al. · JAMA Surgery · 133

PDF

Minimally Invasive Versus Open Pancreaticoduodenectomy

2017 · Ibrahim Nassour, Sam C. Wang, et al. · Annals of Surgery · 125

Does Graded Histologic Response After Neoadjuvant Chemotherapy Predict Survival for Completely Resected Gastric Cancer?

2007 · John C. Mansour, Laura Tang, et al. · Annals of Surgical Oncology · 113

Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility

2017 · Erik S Knudsen, Uthra Balaji, et al. · Gut · 101

PDF

Robotic Versus Laparoscopic Pancreaticoduodenectomy: a NSQIP Analysis

2017 · Ibrahim Nassour, Sam C. Wang, et al. · Journal of Gastrointestinal Surgery · 96

Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes

2015 · Georgios Antonios Margonis, Yuhree Kim, et al. · Annals of Surgical Oncology · 96

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

2015 · Lauren M. Postlewait, Cecilia G. Ethun, et al. · Journal of the American College of Surgeons · 89

Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer

2017 · Ali A. Mokdad, Adam C. Yopp, et al. · JAMA Oncology · 81

PDF

Incidence and comparative outcomes of periampullary cancer: A population‐based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012

2018 · Caitlin A. Hester, Epameinondas Dogeas, et al. · Journal of Surgical Oncology · 77

The Utility of F-18 Fluorodeoxyglucose Whole Body PET Imaging for Determining Malignancy in Cystic Lesions of the Pancreas

2006 · John C. Mansour, Lawrence Schwartz, et al. · Journal of Gastrointestinal Surgery · 73

Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma

2019 · Caitlin A. Hester, Nishika Karbhari, et al. · Cancer · 72

PDF

Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis

2014 · Lauren R. Zeitels, Asha Acharya, et al. · Genes & Development · 68

Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients

2018 · Masato Kobayashi, Jin-Sung Chung, et al. · Clinical Cancer Research · 61

Conversion of Minimally Invasive Distal Pancreatectomy: Predictors and Outcomes

2017 · Ibrahim Nassour, Sam C. Wang, et al. · Annals of Surgical Oncology · 61

Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database

2018 · Caitlin A. Hester, Mathew M. Augustine, et al. · Journal of Surgical Oncology · 59

Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence

2015 · Neda Amini, Georgios Antonios Margonis, et al. · Annals of Surgical Oncology · 59

Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study

2017 · Ibrahim Nassour, Linda S. Hynan, et al. · Journal of Gastrointestinal Surgery · 58

Works count: 261

Citation count: 6,083

H-index: 37

I10-index: 81